Today’s episode features Ollie Ollerton, a former UK Special Forces soldier and directing staff (DS) of Channel 4’s SAS: Who Dares Wins. Mr Ollerton has always been involved in the social cause, serving in the army as well as supporting multiple charities. Thanks to the publicity from SAS: Who Dares Wins he has been, among  …

There is no defined road to legalising psychedelics, but there are many options available. Ismail Lourido Ali, of MAPS, discusses the important nuances in this Drug Science webinar on expanding access to psychedelics. Due to the recent progress of medical cannabis legalisation, many expect psychedelics to follow a similar path of medical legalisation, followed by  …

This is the full recording of our 4th Women in Psychedelic Science event, hosted in June. Featuring experts working at the cutting edge of psychedelic science and in related fieldwork. Psychedelic medicine: from lab findings to therapeutic applications Dr Kim Kuypers Kim PC Kuypers (PhD) is affiliated as an Associate Professor with Maastricht University, Faculty  …

 How can you study yourself and deal with the problems buried deep inside of you? In this week’s episode, Dr Meckel Fischer and Professor Nutt hope to answer these puzzling questions!   Who is Friederike Meckel Fischer?  Friederike Meckel Fischer is a German psychotherapist who also trained as a medical doctor. Her career involved  …

Prof David Nutt and Prof Jan Ramaekers discuss some of the biggest questions in Drug Science in this interview for the European Behavioral Pharmacology Society. They first discuss psychedelics in the treatment of depression, in light of the recent results comparing psilocybin to one of the most commonly prescribed antidepressants. They then address concerns that liberal  …

In this Drug Science webinar, Dr Balázs Szigeti explains the current science of microdosing as he presents the results from his self-blinded microdosing research, the largest placebo-controlled microdosing study in the world! Dr Szigeti also explains how participants created their microdoses with a placebo control as part of the revolutionary methodology he developed to reduce  …

Summary Full Report Survey Data Does the UK support psilocybin research? Public perceptions of psilocybin-assisted therapy have been revealed in a new YouGov poll, commissioned by Drug Science. This is the first nationally representative poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes (such as rescheduling psilocybin) to make this  …